Kiora Pharmaceuticals Q4 EPS $(1.60) Misses $(0.67) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings MissesNews
Kiora Pharmaceuticals (NASDAQ:KPRX) reported quarterly losses of $(1.60) per share which missed the analyst consensus estimate of $(0.67) by 138.81 percent. This is a 61.62 percent decrease over losses of $(0.99) per
Kiora Pharmaceuticals (NASDAQ:KPRX) reported quarterly losses of $(1.60) per share which missed the analyst consensus estimate of $(0.67) by 138.81 percent. This is a 61.62 percent decrease over losses of $(0.99) per share from the same period last year.